Tomorrow at #WCLC2026: Join Zosia Piotrowska, Aaron C. Tan, and Jon Zugazagoitia for a case-based discussion on selecting and sequencing therapy for advanced #HER2-mutant #NSCLC.
1:45-2:45 PM KST
Room 103, Grand Ballroom, 1F
lnkd.in/d9KZ7CfS#NSCLC#lungcancer
Going to #WCLC2026 in Seoul? Do not miss the #PeerVoice industry symposium.
Join Zosia Piotrowska, Aaron C. Tan, and Jon Zugazagoitia, for a case-based discussion on selecting and sequencing systemic therapies for advanced #HER2-mutant #NSCLC.
lnkd.in/d9KZ7CfS
#ESOBlog about #FXIa inhibition & its potential role in secondary #stroke prevention.
Explore emerging evidence from OCEANIC-STROKE & discussions on balance between preventing recurrent stroke & bleeding risk.
A @PeerVoice activity, endorsed by ESO
👉 ow.ly/o51H50ZAKN0
Check out this #CE activity to hear insights from a clinician and a patient advocate on the burden of living with CIDP, its diagnostic and treatment challenges, and novel/emerging therapeutic strategies.
#PeerVoice#CIDP#neurologypeervoice.com/RZR?PromoCode=…
In collaboration with @PeerVoice, ESO invites you to explore this free, on-demand, CE-accredited educational activity examining the potential of investigational Factor XIa inhibition for secondary #stroke prevention.
🎥 Watch now: ow.ly/LTzS50Zy5rv#Neurology
!!!Today is the day!!! - join this CE-accredited virtual live event: lnkd.in/en9uhvVE
Eric Van Cutsem, Florian Lordick, MD, FESMO, and Lorenza Rimassa discuss the practical integration of #HER2-directed therapies across biliary tract, colorectal, and gastric cancers.